Security key
91864C107
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS)
CUSIP: 91864C107
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / American Depositary Shares, each representing one ordinary share
- Total 13F shares
- 9,717,331
- Total 13F value
- $10,336,336
- Share change
- -589,553
- SEC-reported price per share
- $1.21
- Number of holders
- 16
- Value change
- -$702,886
- Number of buys
- 2
- Number of sells
- 7
- Shares outstanding
- 40,291,821
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
16
Top holders
10
BRNS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Barinthus Biotherapeutics plc. SEC filings
Barinthus Biotherapeutics plc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 91864C107
Recent filing periods:
Ownership snapshot
Top reported holders of BRNS - Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Frank W. Cawood
Disclosed value leader
M&G Plc
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 8.4%
13D/G row: Frank W. Cawood
Showing 1-6 of 15 holder rows.
Quick read
Frank W. Cawood leads the comparable SEC ownership view at 8.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Frank W. Cawood's linked filing trail.
Comparable ownership
Top 5
Frank W. Cawood
8.4%
M&G Plc
13%
Alphabet Inc.
3.8%
HSG Holding Ltd
3.5%
DC Funds, LP
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Frank W. Cawood |
13D/G
|
8.4%
|
$3,384,513
3,384,513 shares
|
$0 | 31 Dec 2024 |
| M&G Plc |
13F
Company
|
13%
|
$5,197,349
5,197,349 shares
|
— | 30 Sep 2024 |
| Alphabet Inc. |
13F
Company
|
3.8%
|
$1,801,236
1,513,644 shares
|
— | 30 Sep 2024 |
| HSG Holding Ltd |
13F
Company
|
3.5%
|
$1,889,229
1,420,473 shares
|
— | 30 Sep 2024 |
| DC Funds, LP |
13F
Company
|
1.6%
|
$764,223
642,204 shares
|
— | 30 Sep 2024 |
| BlueCrest Capital Management Ltd |
13F
Company
|
1.3%
|
$645,781
542,673 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
9,717,331
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q1 2026 Across Filers
Q1 2026 holders
14
Q4 2024 holders
16
Holder diff
2
| Investor | Q1 2026 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend